CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 98 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.96 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $5,000 | -50.0% | 26,206 | +22.6% | 0.00% | – |
Q3 2018 | $10,000 | +25.0% | 21,376 | +40.3% | 0.00% | – |
Q2 2018 | $8,000 | -96.9% | 15,236 | -86.0% | 0.00% | -100.0% |
Q1 2018 | $254,000 | 0.0% | 109,216 | +22.3% | 0.00% | 0.0% |
Q4 2017 | $254,000 | +9.5% | 89,286 | +9.8% | 0.00% | 0.0% |
Q3 2017 | $232,000 | +17.2% | 81,286 | +1.4% | 0.00% | 0.0% |
Q2 2017 | $198,000 | -23.3% | 80,136 | +12.2% | 0.00% | 0.0% |
Q1 2017 | $258,000 | +8.4% | 71,420 | +6.1% | 0.00% | 0.0% |
Q4 2016 | $238,000 | +6.2% | 67,336 | +21.7% | 0.00% | 0.0% |
Q3 2016 | $224,000 | +873.9% | 55,346 | +971.4% | 0.00% | – |
Q2 2016 | $23,000 | +27.8% | 5,166 | +8.4% | 0.00% | – |
Q1 2016 | $18,000 | -92.0% | 4,766 | -66.7% | 0.00% | -100.0% |
Q4 2015 | $225,000 | +281.4% | 14,323 | +154.7% | 0.00% | +100.0% |
Q3 2015 | $59,000 | -39.8% | 5,623 | +60.4% | 0.00% | 0.0% |
Q1 2015 | $98,000 | +75.0% | 3,506 | +14.1% | 0.00% | 0.0% |
Q4 2014 | $56,000 | +100.0% | 3,074 | +44.5% | 0.00% | – |
Q3 2014 | $28,000 | -91.6% | 2,128 | -93.4% | 0.00% | -100.0% |
Q2 2014 | $332,000 | +33100.0% | 32,274 | +43513.5% | 0.00% | – |
Q1 2014 | $1,000 | -50.0% | 74 | 0.0% | 0.00% | – |
Q4 2013 | $2,000 | 0.0% | 74 | +37.0% | 0.00% | – |
Q3 2013 | $2,000 | – | 54 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
Overbrook Management Corp | 48,611 | $22,000 | 0.00% |